ESPR
Esperion Therapeutics Inc
Price:  
2.69 
USD
Volume:  
19,076,904.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR WACC - Weighted Average Cost of Capital

The WACC of Esperion Therapeutics Inc (ESPR) is 7.3%.

The Cost of Equity of Esperion Therapeutics Inc (ESPR) is 8.65%.
The Cost of Debt of Esperion Therapeutics Inc (ESPR) is 5.00%.

Range Selected
Cost of equity 7.30% - 10.00% 8.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 8.3% 7.3%
WACC

ESPR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 10.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.38 0.38
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 8.3%
Selected WACC 7.3%